World Tuberculosis Day: Survivors push for access to Delamanid, Bedaquiline

Mumbai | Sunday | 24th March, 2019

Summary:

Until then, minors requiring the life saving drugs, Bedaquiline and Delamanid, have zero access. A group of 10 TB survivors who underwent treatment using Bedaquiline and Delamanid are now pushing the government to make their access easy. India has recently procured 400 Delamanid drugs on donation basis. Kadam fought TB for five years, gradually progressing from TB to MDR, to finally XDR strain before he got access to both Bedaquiline and Delamanid in 2016. “Even if Sewri TB had diagnosed XDR strain, the girls, being minors, would not have received Bedaquiline drug,” MSF clinic incharge Dr Pramila Singh said..